Cargando…

Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection

The emerging threat represented by SARS-CoV-2 variants, demands the development of therapies for better clinical management of COVID-19. MAD0004J08 is a potent Fc-engineered monoclonal antibody (mAb) able to neutralize in vitro all current SARS-CoV-2 variants of concern (VoCs) including the omicron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanini, Simone, Milleri, Stefano, Andreano, Emanuele, Nosari, Sarah, Paciello, Ida, Piccini, Giulia, Gentili, Alessandra, Phogat, Adhuna, Hyseni, Inesa, Leonardi, Margherita, Torelli, Alessandro, Montomoli, Emanuele, Paolini, Andrea, Frosini, Andrea, Antinori, Andrea, Nicastri, Emanuele, Girardi, Enrico, Plazzi, Maria Maddalena, Ippolito, Giuseppe, Vaia, Francesco, Della Cioppa, Giovanni, Rappuoli, Rino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046195/ https://www.ncbi.nlm.nih.gov/pubmed/35477725 http://dx.doi.org/10.1038/s41467-022-29909-x

Ejemplares similares

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
por: Andreano, Emanuele, et al.
Publicado: (2021)

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
por: Andreano, Emanuele, et al.
Publicado: (2020)

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
por: Andreano, Emanuele, et al.
Publicado: (2021)

Influenza Anti-Stalk Antibodies: Development of a New Method for the Evaluation of the Immune Responses to Universal Vaccine
por: Manenti, Alessandro, et al.
Publicado: (2020)

Immunodominant antibody germlines in COVID-19
por: Andreano, Emanuele, et al.
Publicado: (2021)

mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5
por: Andreano, Emanuele, et al.
Publicado: (2023)

2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19
por: Cantini, Francesca, et al.
Publicado: (2022)

N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network
por: Gianchecchi, Elena, et al.
Publicado: (2016)

Monkeypox virus in human body sites and fluids: evidence for transmission
por: Colavita, Francesca, et al.
Publicado: (2023)

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
por: Hyseni, Inesa, et al.
Publicado: (2020)

Prior SARS-CoV-2 Infection Enhances Initial mRNA Vaccine Response with a Lower Impact on Long-Term Immunity
por: Silva-Moraes, Vanessa, et al.
Publicado: (2023)

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
por: Andreano, Emanuele, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant
por: Bordi, Licia, et al.
Publicado: (2023)

Viral replication and infectivity of monkeypox through semen – Authors' reply
por: Lapa, Daniele, et al.
Publicado: (2022)

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development
por: Piccini, Giulia, et al.
Publicado: (2020)

Vaccine Evolution and Its Application to Fight Modern Threats
por: Andreano, Emanuele, et al.
Publicado: (2019)

Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana
por: Frigerio, Rachele, et al.
Publicado: (2022)

Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
por: Baldari, Cosima T., et al.
Publicado: (2023)

A new dawn for monoclonal antibodies against antimicrobial resistant bacteria
por: Troisi, Marco, et al.
Publicado: (2022)

High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae
por: Stazzoni, Samuele, et al.
Publicado: (2023)

Efficacy of MAP0004 in treating severe migraine
por: Kori, S, et al.
Publicado: (2013)

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults
por: Montomoli, Emanuele, et al.
Publicado: (2018)

Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
por: Gianchecchi, Elena, et al.
Publicado: (2022)

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
por: Torres, Jonathan L., et al.
Publicado: (2022)

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
por: Andreano, Emanuele, et al.
Publicado: (2023)

Efficacy and Safety of Anticoagulant Therapy in COVID-19-Related Pulmonary Embolism with Different Extension
por: Gatto, Maria Chiara, et al.
Publicado: (2023)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
por: Dapporto, Francesca, et al.
Publicado: (2022)

Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
por: Mazzini, Livia, et al.
Publicado: (2021)

Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH
por: Gagliardini, Roberta, et al.
Publicado: (2022)

Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
por: Mondi, Annalisa, et al.
Publicado: (2023)

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
por: Andreano, Emanuele, et al.
Publicado: (2021)

Incidence of SARS-CoV-2 Infection and Related Mortality by Education Level during Three Phases of the 2020 Pandemic: A Population-Based Cohort Study in Rome
por: Angelici, Laura, et al.
Publicado: (2022)

Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
por: Mazzotta, Valentina, et al.
Publicado: (2022)

The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 “doublethink” effect
por: Manenti, Alessandro, et al.
Publicado: (2021)

Flow cytometry as an integrative method for the evaluation of vaccine immunogenicity: A validation approach
por: Gianchecchi, Elena, et al.
Publicado: (2023)

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
por: Agrati, Chiara, et al.
Publicado: (2022)

Viral hemorrhagic fevers: advancing the level of treatment
por: Ippolito, Giuseppe, et al.
Publicado: (2012)

The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac
por: Tonnara, Giuseppe, et al.
Publicado: (2022)

In Vitro and In Vivo Crosstalk between Type I IFN and IL-8 Responses in SARS-CoV-2 Infection
por: Biava, Mirella, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ipfru94oe9cv8sdnkbcmtu216a